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Summary
Plasmodium falciparum malaria is a major cause of
morbidity and mortality in African children, and
factors that determine the development of uncom-
plicated (UM) versus cerebral malaria (CM) are not
fully understood. We studied the ex vivo respon-
siveness of microvascular endothelial cells to
pro-inflammatory stimulation and compared the
findings between CM and UM patients. In patients
with fatal disease we compared the properties of
vascular endothelial cells cultured from brain
tissue to those cultured from subcutaneous tissue,
and found them to be very similar. We then isolated,
purified and cultured primary endothelial cells from
aspirated subcutaneous tissue of patients with CM
(ECCM) or UM (ECUM) and confirmed the identity of
the cells before analysis. Upon TNF stimulation
in vitro, ECCM displayed a significantly higher
capacity to upregulate ICAM-1, VCAM-1 and CD61
and to produce IL-6 and MCP-1 but not RANTES
compared with ECUM. The shedding of endothelial
microparticles, a recently described parameter of
severity in CM, and the cellular level of activated
caspase-3 were both significantly greater in ECCM
than in ECUM. These data suggest that inter-
individual differences in the endothelial inflamma-
tory response to TNF may be an additional factor
influencing the clinical course of malaria.
Introduction
Cerebral malaria (CM) is an important life-threatening
complication of Plasmodium falciparum infection. This
neurological syndrome occurs in about 1% of infections
but exhibits significant case fatality rates, contributing
up to a million deaths annually among children in
sub-Saharan Africa (Rowe et al., 2006). The patho-
physiological mechanisms underlying CM are not fully
understood and several hypotheses have been put
forward, including mechanical obstruction of microves-
sels by P. falciparum-parasitized red blood cells (PRBC)
and hyper-activation of host immune cells leading to
the excessive release of pro-inflammatory cytokines
(Berendt et al., 1994; Clark and Rockett, 1994; Grau and
de Kossodo, 1994). These complementary theories may
contribute to our understanding of pathogenesis, but
they fail to explain why only a small percentage of
malaria patients develop CM.cmi_1528 198..209
Sequestration of PRBC within brain microvasculature
is a common feature of CM, and this phenomenon
is mediated by several endothelial cell (EC) adhesion
molecules including inter-cellular adhesion molecule
(ICAM)-1, CD36, P-selectin and vascular cell adhesion
molecule (VCAM)-1 (Ho and White, 1999). Most of
these receptors are inducible in endothelium by pro-
inflammatory cytokines such as TNF, a cytokine that
has been postulated to play a crucial role in the
pathogenesis of CM (Grau et al., 1989; Hunt and
Grau, 2003). In P. falciparum-infected patients, the
surface expression of vascular endothelial receptors
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has been shown to be increased in several tissues
at post-mortem, including the brain. A colocalization of
PRBC and these receptors has also been observed,
suggesting that endothelial activation plays a role in
sequestration, and therefore potentially in pathoge-
nesis (MacPherson et al., 1985; Turner et al., 1994). In
addition to the upregulation of endothelial receptors
mediating PRBC sequestration, TNF induces extensive
alterations in microvascular EC including morphological
reorganization (Pober and Cotran, 1990), release of
membrane microparticles (MP) (Zwaal and Schroit,
1997), production of pro-inflammatory cytokines and
apoptosis (Grell et al., 1999; Gnant et al., 2000; Kimura
et al., 2003).
In an experimental model for CM, it has been reported
that brain EC purified from CM-susceptible and
CM-resistant mice exhibit different sensitivities to TNF.
Brain EC isolated from susceptible mice had a greater
capacity to produce interleukin (IL)-6 and to upregulate
ICAM-1 and VCAM-1 in response to TNF than did brain
EC from resistant mice (Lou et al., 1998). On this basis,
we postulated that differences in the severity of human
malarial disease might in part be due to a differential
responsiveness of the host endothelium to systemic
inflammation.
We studied the effect of TNF on cultured EC originat-
ing from Malawian children with different clinical syn-
dromes. We compared upregulation of cytoadherence
receptors, shedding of MP, release of chemokines and
cytokines selected for their relevance in the pathophysi-
ology of malaria and activation of pro-apoptotic factors
in EC cultured from patients in the different clinical
groups. Since the isolation, purification and culture of
brain vascular EC is feasible only through post-mortem
sampling, we used subcutaneous adipose tissue
as a source of vascular EC from all patient groups.
Wilairatana and colleagues described focal cytokine
accumulations in the skin that were similar to those in
the brain (Wilairatana et al., 2000). This was recently
confirmed in humans, where the subcutaneous adipose
tissue, but not dermal or epidermal skin layers, was a
major site for sequestration (Seydel et al., 2006).
Nakano and colleagues reported a correlation between
PRBC sequestration in subcutaneous tissues and in
brain microvasculature in a primate model of CM
(Nakano et al., 1996).
In view of these data, and considering that purification
and isolation of fat-derived EC has been extensively
described and can be performed routinely in living
patients (Kern et al., 1983), EC derived from human
subcutaneous fat appeared to represent an original
and relevant alternative model to test our hypothesis
and compare endothelial reactivity to TNF in patients
with uncomplicated malaria (UM) and CM.
Results
Success rates of brain and subcutaneous fat
cell preparations
The success rate of skin cell preparation from tissue
samples was of 73.3%, with six successful preparations
out of eight UM patients and five out of eight CM patients
respectively. In the case of brain cell preparations, we
obtained six cell cultures out of the same eight patients
(75% of success) but restricted our analyses to the five
patients we successfully isolated, purified and cultured
both brain and fat EC. The loss of approximately 25% of
our samples in both patient categories was mainly due to
either bacterial or fungal contamination, a risk consider-
ably increased by the collection of tissue samples in a
non-sterile environment (i.e. ward or mortuary). In one
case of brain EC preparation, cells stopped growing after
2 days in culture with no known explanation.
Comparison of morphological and phenotypical
characteristics between subcutaneous fat and
brain-derived ECCM
Brain and subcutaneous fat-derived primary ECCM readily
adhere to plastic substrate, form flat monolayers after
plating in culture flasks, present a thin cobblestone-like
morphology with central and prominent nuclei after 3
days in culture, and exhibit contact inhibition (Fig. 1). All
of the primary ECCM constitutively expressed typical
endothelial markers including von Willebrand factor
(vWF) and platelet-endothelium cell adhesion molecule
(PECAM)-1 (CD31), and showed an E-selectin (CD62E)
inducible expression upon TNF stimulation, as shown in
Fig. 1 and Table 1. Brain and subcutaneous fat EC con-
stitutively expressed high levels of ICAM-1 (Fig. 1), avb3
integrin (CD51/CD61), CD146 and VCAM-1, and both
ICAM-1 and VCAM-1 were significantly upregulated
upon TNF stimulation (Table 1). However, brain-derived
primary EC exhibited a peripheral pattern of positive
staining for ZO-1, a constituent of endothelial tight junc-
tions, as well as no CD36 expression, whereas subcuta-
neous fat EC did not express ZO-1 but were stained
positively for CD36 (Fig. 1).
Variation of ICAM-1, VCAM-1 and CD61 upregulation in
subcutaneous fat ECCM and ECUM in the presence of a
pro-inflammatory stimulus
Under resting conditions, the basal expression of ICAM-1,
VCAM-1 and CD61 did not show any significant difference
between ECCM and ECUM in cell-based ELISA assays
using subcutaneous fat ECs. In contrast, upon overnight
stimulation with increasing doses of TNF, cells of both
patient categories exhibited a dose-dependent upregula-
Endothelium reactivity in malaria patients 199
© 2010 Blackwell Publishing Ltd, Cellular Microbiology, 13, 198–209
tion of the three surface molecules. When the dose of TNF
reached a range between 1 and 10 ng ml-1, a significantly
higher upregulation of ICAM-1 (P < 0.05 and P < 0.001,
respectively, Fig. 2A) and CD61 (P < 0.05 and P < 0.01,
respectively, Fig. 2C) was observed in ECCM compared
with ECUM. In the case of VCAM-1, a significant difference
was only observed at a TNF concentration of 10 ng ml-1
(P < 0.05, Fig. 2B). All these results were confirmed by
flow cytometry at the highest TNF concentration
(10 ng ml-1, Fig. 2D–F). Brain-derived ECCM were also
used as a comparator and when stimulated with the most
effective dose of TNF no differences were observed in
Fig. 1. Immunofluorescence analysis of endothelial markers on subcutaneous fat and brain-derived ECCM monolayers. The figure shows
evidence for the expression of several typical endothelial markers on submembrane or cell type surface, including vWF, CD31, ZO-1, ICAM-1,
CD36 and CD62-E. Micrographs presented here are from patient PM91-derived cells in passage 3 and are representative of the results
obtained with all the other CM patients. Magnification: ¥ 100 for general morphology micrographs, ¥ 400 for immunofluorescence micrographs.
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terms of ICAM-1, VCAM-1 and CD61 upregulation, when
compared with subcutaneous fat-derived ECCM (data not
shown).
Shedding of endothelial membrane MP
ECCM and ECUM were exposed to two concentrations of
TNF, for which significant effects have been observed in
previous assays (1 and 10 ng ml-1 respectively), to
compare MP formation. Both cell types produced signifi-
cantly higher MP numbers than in resting conditions and a
dose-dependent increase of MP production was observed
(Fig. 3). In both stimulation conditions the number of MP
released by 1000 EC was significantly higher in ECCM than
in ECUM (P < 0.01), ECCM releasing up to 5420 MP per
1000 EC when stimulated with 10 ng ml-1 TNF (Fig. 3).
Table 1. Flow cytometric phenotyping of ECCM under resting and activated conditions.
CD Antigen Clone
Subcutaneous fat ECCM Brain ECCM
Resting TNF Resting TNF
MFI (a.u.) % POS MFI (a.u.) % POS MFI (a.u.) % POS MFI (a.u.) % POS
IgG1 0.23 0.21 0.19 0.22
CD31 PECAM-1 5.6E 30 89 34.7 78.9 25.9 78.8 27.3 81.4
CD36 GPIV FA6-152 37.2 48.2 40.3 51 0.23 0.7 0.26 0.9
CD40 Bp50 B-B20 0.42 2.8 0.46 6.1 0.24 3.5 0.6 6.3
CD51 av AMF7 20.2 100 19.7 100 24.3 100 25.8 100
CD54 ICAM-1 84H10 43.8 94.7 84.6 96 35 92.7 79.8 90.6
CD61 b3 SZ21 2.1 100 34.1 100 3.7 100 31.6 100
CD62E E-selectin CL2/6 0.26 2 0.32 2.7 0.4 1.3 0.22 0.7
CD106 VCAM-1 1G1 5.6 80 27.1 78.3 4.1 82.6 24.7 81.1
CD146 MCAM OJ79c 28.1 76 25.9 72.7 23 89.3 21.5 92.1
Subcutaneous fat- and brain-derived EC isolated from patients who died of CM were either left unstimulated or activated with TNF (10 ng ml-1) and
stained by indirect immunolabelling after 12 h, except for CD62E, which was studied after 6 h. Results are representative of a series of three
experiments performed in passage 2 and show both the mean fluorescence intensity (MFI) expressed in arbitrary units (a.u.) of the labelling with
specific monoclonal antibodies and also the percentage of cells positively labelled with these antibodies in the whole population.
Fig. 2. Comparison of TNF-induced adhesion molecule upregulation between ECUM and ECCM of subcutaneous fat origin. Cells were seeded
in a 96-well plate and stimulated by increasing concentrations of TNF. ECUM and ECCM were then fixed and the expression of ICAM-1, VCAM-1
and CD61 was measured by cell-based ELISA (A, B and C respectively). Results are expressed as mean  SD of two experiments (Dunn’s
test, *P < 0.05, **P < 0.01 and ***P < 0.001). As a control, each experiment was confirmed by flow cytometry (D–F). The results of one
representative reading obtained with the greatest concentration of TNF are shown here.
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MCP-1, RANTES and IL-6 release by ECCM and ECUM
upon TNF stimulation
To determine whether the release of MCP-1, RANTES
and IL-6 by ECUM and ECCM varied upon inflammatory
stimulus, we performed a series of ELISA in the presence
of increasing concentrations of TNF, ranging from 0.01 to
10 ng ml-1. The release of both MCP-1 and IL-6 was
induced by TNF in ECUM and ECCM and this effect was
dose-dependent. Significantly higher levels of MCP-1 and
IL-6 were produced by ECUM than by ECCM when TNF
concentrations reached 1 and 10 ng ml-1 respectively
(Fig. 4). Conversely, there was no significant effect of TNF
on release of RANTES by either cell types, nor was there
a clear tendency or statistically significant difference in its
production between ECCM and ECUM (Fig. 4).
Activation of caspase-3 in TNF-stimulated ECCM
and ECUM
The level of activated caspase-3 in ECCM than in ECUM
was clearly modulated by the amount of cytokine added to
the medium. Caspase-3 activation was significantly
higher in ECCM than in ECUM at TNF concentrations of
0.1 ng ml-1 and above (P < 0.05).
Fig. 3. Quantification of TNF-induced endothelial MP release by
subcutaneous fat-derived ECUM and ECCM. Cells were cultured and
left resting or stimulated with TNF for 6 h before analysis. MP
production was quantified by flow cytometry for each condition.
Results (two determinations in three experiments) are expressed in
numbers of MP labelled with annexin V-FITC, extracted from
culture supernatants of 1000 EC (Dunn’s test, **P < 0.01).
Fig. 4. Comparison of TNF-induced
production of MCP-1, RANTES, IL-6 and
cleaved Caspase-3 between ECUM and ECCM.
Subcutaneous fat-derived EC from both
patient categories were stimulated with
different doses of TNF. In the case of MCP-1,
RANTES and IL-6, supernatants were
collected after 12 h of incubation and
concentrations were measured by ELISA. For
activated Caspase-3, supernatants and cell
extracts were pooled before analysis by
ELISA. Results are expressed as mean  SD
of three determinations in two experiments
(Dunn’s test, *P < 0.05 and ***P < 0.001).
202 S. C. Wassmer et al.
© 2010 Blackwell Publishing Ltd, Cellular Microbiology, 13, 198–209
Discussion
A central component of CM pathophysiology appears to
be the activation of microvascular EC, resulting both
from the cytoadherence of infected erythrocytes to EC
and from the pro-inflammatory effects of locally released
cytokines (Wassmer et al., 2003). The consequences of
this endothelial inflammation are numerous and include:
(i) the upregulation of endothelial receptors, enhancing
PRBC sequestration, (ii) an increased shedding of
endothelial MP, (iii) further release of cytokines and
chemokines, and (iv) the trigger of a TNF-dependent
pro-apoptotic pathway (as reviewed in Combes et al.,
2006). Since brain microvascular EC are profoundly
affected in these ways by TNF, variation in the respon-
siveness of EC to TNF in different individuals could be a
factor affecting the severity of disease in patients with
malaria.
Several studies indicate that microvascular EC differ
from large vascular EC in morphology or function (Grau
and Lou, 1993), and EC derived from different organs
also differ in response to some cytokines (Belloni et al.,
1992). In addition, there are considerable variations in
both adhesion molecule expression and the functional
properties of EC depending on their position within the
vascular bed of a particular tissue (Ley et al., 1992). To
examine the possibility that our findings with cultured
subcutaneous fat-derived EC might not reflect the prop-
erties of intracerebral vascular EC, we took the oppor-
tunity to examine EC from both brain and subcutaneous
fat in patients dying of CM who came to autopsy. Both
EC types exhibited similar endothelial features. Cells
of both origins were shown to express major pro-
inflammatory cytokine-induced endothelial adhesion mol-
ecules such as VCAM-1 and ICAM-1 (Springer, 1990),
which were upregulated to a similar degree upon acti-
vation by TNF (Table 1). Two discrepancies confirming
previously published data were observed between sub-
cutaneous fat- and brain-derived ECCM: the former
expressed CD36 and not ZO-1 whereas the latter
expressed ZO-1 but not CD36. ZO-1 plays a crucial role
in the permeability of the blood–brain barrier (Staddon
et al., 1995), and its presence has been widely acknowl-
edged as a hallmark of adjacent brain EC (Collins et al.,
2006). In contrast, the expression of CD36, a non-
inducible receptor for PRBC, has been reported to be
low and irregular in cerebral microvasculature in several
studies (Turner et al., 1994), as opposed to microvascu-
lar beds from subcutaneous and visceral adipose tissue
(Bonen et al., 2006). However, these two differences
were irrelevant to our study since variation in EC mono-
layer permeability was not one of our read-out param-
eters and CD36 expression is not regulated by TNF. Our
results show that EC cultured from subcutaneous fat
closely resemble cerebral vascular EC in several prop-
erties relevant to the pathogenesis of malaria, which
suggests they may be useful in an ex vivo model.
Making use of this model, we have shown that subcu-
taneous fat-derived ECCM and ECUM display significantly
different ex vivo responsiveness to TNF. We demon-
strated that, when compared with ECUM responses, ECCM
express significantly higher levels of ICAM-1, VCAM-1
and CD61, produce more endothelial MP, MCP-1 and IL-6
and are more prone to undergo apoptosis upon stimula-
tion with TNF.
While sequestration of PRBC in the brain has been
widely described in malaria, its association with disease
severity and especially with CM is still debated. Specific
binding of PRBC to ICAM-1 has been reported to be
higher in CM patients compared with patients with uncom-
plicated disease (Newbold et al., 1997). Our results are in
line with the former, and indicate that ECCM upregulate
much higher levels of ICAM-1 on their surface than ECUM,
providing an increased number of PRBC binding sites.
This inter-individual difference in ICAM-1 upregulation
upon TNF stimulation has also been described in human
umbilical vein EC (HUVEC). In a recently published study,
Beck and colleagues isolated 30 lines of HUVEC and
upon stimulation with TNF, some EC, i.e. type I respond-
ers, displayed a low ICAM-1 upregulation while type II
responders exhibited a significantly higher level of the
receptor (Beck et al., 2006). However, we cannot exclude
the possibility of a long-lasting effect of malaria parasite-
derived glycosylphosphatidylinositol, which has been
reported to alter cell-surface expression of various adhe-
sion molecules on HUVEC (Schofield et al., 1996). Such
stimulation could well alter the progeny of cells derived
from patients with severe malaria despite their time in
culture.
In addition to ICAM-1, VCAM-1 and CD61 upregulation
was also shown to be more pronounced in ECCM com-
pared with ECUM. Since VCAM-1 acts as a receptor for
PRBC (Ockenhouse et al., 1992), this phenomenon might
also contribute to the amplification of sequestration in CM
patients. The upregulation of CD61, which is involved in
the binding of activated platelets to EC, may account for
the phenomenon of platelet accumulation in cerebral
microvessels, a histological feature of fatal CM (for review
see Moxon et al., 2009). However, no commensurate
upregulation of CD51, its pairing beta integrin chain to
form the avb3 receptor, was measured and the signifi-
cance of this finding will require further investigation.
Inter-individual differences in the endothelial inflamma-
tory response to TNF in our study also included the pro-
duction of membrane MP. A recent study in Malawian
children demonstrated significantly higher levels of cir-
culating endothelial MP during the acute phase of CM
compared with levels observed in parasitaemic controls.
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Levels of endothelial MP correlated positively with
plasma levels of TNF and returned to normal following
recovery (Combes et al., 2004). In the present study, in
vitro cultures of ECCM released significantly higher
numbers of MP when exposed to TNF than did cultures
of ECUM. We do not know whether this increased release
plays a role in the cascade of events leading to CM,
but recent analyses in a mouse model provided evi-
dence for both pro-inflammatory and pro-coagulant
effects of MP (Combes et al., 2005), suggesting that MP
could potentially enhance the severity of intracerebral
pathology.
In addition to monocytes, the vascular endothelium is a
major source from which circulating cytokines and
chemokines can be derived, especially in inflammatory
conditions. This is particularly true for IL-6, MCP-1 and
RANTES (Krishnaswamy et al., 1999). Using the ex vivo
model we showed that ECUM release less MCP-1 and IL-6
under TNF stimulation than ECCM, while the release of
RANTES is similar in both groups. MCP-1 is a CC
chemokine produced by macrophages and EC in
response to diverse stimuli, including TNF (Murao et al.,
1999), attracting both monocytes and lymphocytes (Carr
et al., 1994). Mononuclear leucocytes have been identi-
fied among the sequestered cells in brain venules in fatal
paediatric CM (Grau et al., 2003), and monocytes
expressing the appropriate ligand can bind to ICAM-1.
Local MCP-1 release coupled to upregulation of ICAM-1
might together be responsible for both the recruitment and
the binding of monocytes on cerebral microvasculature
(Beekhuizen et al., 1990).
Like MCP-1, RANTES is a chemokine that can be
released by EC under a pro-inflammatory stimulus, but
there was no difference in RANTES production in cells
from both patient categories. These results suggest a
selective triggering by TNF of the expression and secretion
of MCP-1 but not of RANTES, similar to the one reported in
studies of human herpesvirus 8-infected HUVEC cultures
(Caselli et al., 2007). Alternatively, there may be a post-
transcriptional inhibition of RANTES release. Our findings
are in keeping with the reported observation that low
plasma levels of RANTES are associated with mortality in
children with CM (John et al., 2006).
The higher level of IL-6 by ECCM than ECUM observed in
this study is in line with data showing that elevated plasma
levels of IL-6 are associated with severe malaria (Larkin
et al., 2009). IL-6 together with TNF can increase cerebral
EC permeability (Duchini et al., 1996), which could con-
tribute to the cerebral oedema observed in CM (Patnaik
et al., 1994). IL-6 might also aggravate PRBC and leuco-
cyte cytoadherence by upregulating ICAM-1 and VCAM-1
on the EC surface (Watson et al., 1996). IL-6 has been
reported to inhibit the ability of plasma enzyme
ADAMTS13 to cleave full-length VWF (Bernardo et al.,
2004), possibly leading to procoagulant events character-
istically seen in severe malaria, including the adhesion
and clumping of platelets to circulating or endothelial
surface-anchored ultra large VWF multimers (Bridges
et al., 2010).
The induction of endothelial apoptosis during CM has
been widely described in both in vitro (Wassmer et al.,
2006) and murine models of the pathology (Wiese et al.,
2006). Its occurrence in vivo during human CM, however,
remains debated. In the present study we observed a
significantly higher level of caspase-3 cleavage in ECCM
compared with ECUM, which is consistent with previous
results. However, since circulating levels of the cytokine
rarely exceed 1 pg ml-1 during human malaria infection,
the induction of apoptosis is likely to involve a massive
local release of TNF in areas of intense sequestration.
This is in line with previous reports of focal accumulation
of TNF in the brain of patients who died of CM (Udom-
sangpetch et al., 1997). Whether these findings accu-
rately reflect the completion of the whole pro-apoptotic
cascade in vivo is not known.
Taken together, our findings demonstrate a difference
in responsiveness to TNF between EC derived from CM
patients and those derived from UM patients. One expla-
nation for this difference might be that EC responsive-
ness in vitro is affected by the severity of disease in the
patient from whom the EC were collected. This explana-
tion is unconvincing, because the EC with which we
worked had been cultured through several cell cycles
during a period of up to 3 weeks. Any influence of con-
ditions prevailing in vivo is unlikely to have persisted
throughout this period. An alternative explanation is that
there is an inherent diversity among individuals in the
responsiveness of their vascular EC to pro-inflammatory
stimuli. This might result from (i) a variation in TNF
‘intake’ by the cells, (ii) a long-term effect due to specific
P. falciparum exposure, (iii) a genetic inter-individual
variation in reactivity to inflammation or (iv) a combina-
tion of all the factors. The differences we observed
between ECCM and ECUM would then suggest that greater
antecedent EC responsiveness predisposed some indi-
viduals to the development of more severe disease.
Inherent diversity of individuals in the responsiveness of
their EC to TNF stimulation has recently been reported
by Beck and colleagues in a study of cultured lines of
HUVEC (Beck et al., 2006) and in the fever effect on
PRBC cytoadherence in individual HUVEC isolated from
Kenyan mothers (A.G. Craig, unpubl. data). In addition, a
recent study in Ugandan children and Thai adults
revealed that TNF levels do not clearly discriminate
between UM and CM patients (Lovegrove et al., 2009),
suggesting that a differential responsiveness to this
cytokine rather than a differential production might
account for the clinical outcome of malaria infection.
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Experimental procedures
Patients
We studied cases of UM and CM admitted to the paediatric
research ward of the Queen Elizabeth Central Hospital, Blantyre,
Malawi between January 2007 and August 2009. All patients with
UM (n = 6; four males and two females; mean age 4.7 years,
mean parasitaemia 53 349 parasites ml-1, parasitaemia range
151 500) had P. falciparum parasitaemia and a packed cell
volume above 25% and were fully conscious (Blantyre coma
score 5/5). UM patients’ relatives gave fully informed consent for
a subcutaneous fat tissue sample to be taken. This was per-
formed by needle aspiration using a hollow bore ‘menghini’
needle on the upper external thigh after application of local
anaesthetic cream for 2 h to temporarily numb the surface of the
skin (EMLA Cream 5%, AstraZeneca). Patients with CM (n = 7;
five males and two females; mean age 3.3 years, mean parasi-
taemia 43 141 parasites ml-1, parasitaemia range 90 724) were
admitted to the hospital in coma (Blantyre coma score 2/5 or
less), had P. falciparum parasitaemia with no other clinically
evident cause of unconsciousness and were found to have
malarial retinopathy (for review, see Beare et al., 2006). They
were treated with quinine, as described elsewhere (Taylor et al.,
2004). Two patients who recovered had subcutaneous fat tissue
sample collected in the ward as described above. Five patients
died of CM and once consent was granted from parents or
guardians (Taylor et al., 2004), a full autopsy was conducted at
the mortuary of the Queen Elizabeth Central Hospital, during
which brain and subcutaneous fat tissue samples were collected
(approximately 5 mm3). The autopsy or the subsequent histologi-
cal studies confirmed the diagnosis for these five CM patients.
This study was conducted according to the principles expressed
in the Declaration of Helsinki and was approved by the ethical
review committees of the College of Medicine, University of
Malawi, the Liverpool School of Tropical Medicine and Michigan
State University. The parents, relatives or guardians of all
patients provided written informed consent for the collection of
samples and subsequent analysis.
Isolation, purification and culture of EC derived from
patients
Subcutaneous fat tissue-derived EC were obtained from all
patients (fatal CM at autopsy and UM in the ward, Fig. 5) while
brain EC were only obtained in fatal CM cases (Fig. 6). For clarity,
EC derived from CM patients will be referred to as ECCM and EC
derived from UM patients as ECUM. Cells were isolated following
a protocol adapted from Hutley et al. (2001) as described below.
Isolation. Briefly, biopsies were transported to the laboratory in
PBS and transferred to gentleMACSTM Dissociator C-tubes
(Miltenyi Biotec). Both brain and subcutaneous tissues were
treated as follows: (i) samples were finely minced and incubated
for 15 min at 37°C in digest solution (in mM: 25 Hepes, 5 glucose,
120 sodium chloride, 50 potassium chloride and 1 calcium chlo-
ride) containing 3 mg ml-1 type II collagenase and 1.5% bovine
serum albumin (BSA). The ratio of digest solution to tissue was
4:1. C-tubes were then connected to the gentleMACSTM Disso-
ciator and spun for 60 s before being incubated for 15 additional
minutes at 37°C. The operation was repeated three times. The
resultant digest material was filtered through a 250 mm mesh
(Sefar), and adipocytes and free oil were separated from the
stromovascular components by centrifugation at 250 g for 5 min
at 4°C. (ii) The stromovascular pellet was resuspended, washed
and centrifuged in DPBS containing 10% BSA (500 g, 5 min,
4°C). This was repeated and followed by a final wash in DPBS
alone. (iii) The resulting pellet was incubated in 0.25% trypsin
containing 1 mM EDTA (Invitrogen) for 15 min at room tempera-
ture with gentle automated agitation. Trypsin was neutralized by
addition of Hanks’ balanced salt solution (HBSS) containing 5%
fetal bovine serum (FBS; Sigma). (iv) Large fragments of con-
nective tissue were then removed by filtration through 100 mm
mesh (Sefar). (v) The filtrate was centrifuged (500 g, 5 min, 4°C),
and the pellet was resuspended and plated into 1% gelatine-
coated 25 cm2 culture flasks (Corning) in DMEM-F12 medium
(Invitrogen) supplemented with EGM-2 MV SingleQuots (Lonza),
150 mg ml-1 EC growth supplement (ECGS, Sigma) and
30 ng ml-1 b-EC growth factor (b-ECGF). This mixed cell popu-
lation was cultured for 3–5 days at 37°C in 5% CO2.
Selection of microvascular endothelial cells (MVEC) with anti-
CD31 Dynabeads. After a culture period of 7–10 days, the cells
were incubated with Trypsin-EDTA for 4–5 min at 37°C, followed
by neutralization of trypsin with HBSS containing 5% FBS and
centrifugation. The pelleted cells were resuspended in 1 ml of
Fig. 5. Schematic representation of needle aspiration biopsy. The
diagram shows the technique used to isolate subcutaneous
fat-derived fat EC by inserting a hollow bore ‘menghini’ needle in
the upper external thigh of patients with malaria (UM and CM) after
application of a local anaesthetic for 2 h. A strong manual
aspiration force represented by the arrow allowed the sampling of
approximately 5 mm3 of adipose tissue, from which EC were
isolated, selected and cultured before analysis.
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PBS containing 0.1% FBS and incubated with 50 ml of anti-CD31-
coated Dynabeads under gentle agitation (20 min, 4°C). The
cell/bead suspension was brought to a total volume of 10 ml with
0.1% FBS in PBS, and EC were selected using a magnetic
particle concentrator for 3 min at room temperature. With the
tube still in the magnet, non-selected cells were discarded and
EC were then washed with a further 10 ml of PBS containing
0.1% FBS and reselected using the magnetic particle concentra-
tor (3 min). This wash/selection procedure was repeated five
times. Selected cells (EC) were plated on to 1% gelatin-coated
culture flask in EC growth medium as described above.
Cell culture. Cells were maintained at 37°C in an atmosphere of
5% CO2. The medium was changed every 2–3 days. As EC
numbers increased, the concentration of b-ECGF in the growth
medium was decreased from 30 to 10 ng ml-1. Brain and subcu-
taneous fat tissue-derived EC were used in experimental work
between passages 2 and 4.
Characterization and phenotypic comparison of
subcutaneous fat and brain-derived ECCM
In order to assess the relevance of subcutaneous fat-derived
EC as a representative model for cerebral endothelium, cells
obtained from brain and adipose tissue at autopsy were charac-
terized and compared as described below.
Morphology. Cultures were examined by inverted phase-
contrast microscopy for the characteristic cobblestone-like mor-
phology of EC.
Immunofluorescence. Confluent EC were rinsed with PBS,
fixed with 1% w/v of paraformaldehyde (PFA) for 15 min on
ice, washed with PBS and incubated with FITC-coupled
mouse anti-human CD31, CD54, CD36 (PECAM-1, clone
5.6E; ICAM-1, clone 84H10 and clone FA6.152, Beckman
Coulter Immunotech), mouse anti-human VWF (clone F6/86,
DAKO Cytomation) revealed by a secondary goat
anti-mouse Alexa488® -coupled mAb (Molecular Probes) or
FITC-coupled anti-ZO-1 (clone ZO-1-1A12, Zymed Laboratory).
A non-specific isotype-matched mouse IgG1 (Beckman-
Coulter Immunotech) was used for all controls. The expre-
ssion of E-selectin (CD62E) was also investigated by use of
a monoclonal antibody (clone CL2/6, Serotec) revealed by a
secondary goat anti-mouse Alexa594®-coupled mAb (Molecular
Probes). In this case, the immunofluorescence analysis
was performed with cells pre-treated for 6 h with TNF
(10 ng ml-1, Sigma).
Fig. 6. Method for sampling and isolating ECCM from brain and subcutaneous fat tissue. ECCM were collected at autopsy and isolated from both
subcutaneous fat and brain tissue from patients who died of CM (n = 7). Brain ECCM were only used for a phenotypical comparison with subcuta-
neous fat-derived ECCM in the first part of our study to assess the relevance of the latter as an accurate model of cerebral endothelium.
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Flow cytometry. Confluent monolayers of EC were stimulated, or
not, with TNF (overnight or 6 h, 10 ng ml-1) before analysis. EC
were then harvested by a short trypsin-EDTA treatment, washed,
and labelled by indirect labelling using mouse anti-human
CD106, CD54, CD51, CD61, CD31, CD36 (Beckman-Coulter
Immunotech), CD40 (Diaclone), CD62E and CD146 (Serotec)
mAbs as first step (as detailed in Table 1) and then with second-
ary goat anti-mouse Alexa488® -coupled mAb (Molecular Probes,
Eugene, USA). A non-specific isotype-matched mouse IgG1
(Beckman-Coulter Immunotech) was used for all controls. Cells
were then resuspended in PBS before flow cytometry analysis on
a FACScalibur (Becton Dickinson). Alexa488® signal was
detected in the FL1 channel (488 nm laser and 530/30 band-pass
filter). The area corresponding to EC was defined, and mean
fluorescence intensities (MFI) of the positive cell populations
were measured for each antigen.
Determination of adhesion molecules expression by
TNF-activated ECUM and ECCM using cell-based ELISA
and flow cytometry
Endothelial cells were seeded on 1% gelatin pre-coated flat-
bottom 96-well plates (104 cells well-1) and grown to confluence.
Cells were then washed with DMEM-F12 medium and stimulated
overnight separately with increasing concentrations of TNF (0,
0.01, 0.1, 1 and 10 ng ml-1). After stimulation, cells were washed
a second time with DMEM-F12, fixed with -20°C methanol for
15 min at room temperature and incubated with PBS containing
5% FCS and 0.05% Tween (Merck) to block non-specific binding.
Cells were then incubated, respectively, with monoclonal antibod-
ies to human ICAM-1, VCAM-1, CD61 (Beckman-Coulter Immu-
notech) and CD62-E (Serotec), all at 10 mg ml-1 for 40 min at
room temperature. For ELISA, the plate was then washed three
times in PBS/Tween 20 and incubated for 45 min under mild
shaking with 1 mg ml-1 goat anti-mouse IgG alkaline phos-
phatase conjugate (Promega). Cells were then washed twice with
HBSS containing 5% BSA and once with 2.5 M diethanolamine
(pH 9.5). Finally, the substrate solution was added, consisting of
0.58 mg ml-1 Attophos fluorescent substrate (Promega) and
2.4 mg ml-1 endogenous phosphatase activity blocking agent
levamisole hydrochloride (Sigma), diluted in diethanolamine
buffer. After 5 min, fluorescence was measured at an excitation
wavelength 450 nm and an emission wavelength 580 nm in an
automated ELISA reader. For flow cytometry analysis, cells were
grown to confluence in 12-well plates and stimulated overnight
with 10 ng ml-1 TNF. EC were then harvested by a short trypsin-
EDTA treatment, washed, and labelled with monoclonal antibod-
ies to human anti-ICAM-1, VCAM-1, CD61 (Beckman-Coulter
Immunotech) and CD62-E (Serotec) as described above.
Analysis of MP production by ECUM and ECCM by flow
cytometry
Confluent ECUM and ECCM were left unstimulated or activated by
TNF (1 and 10 ng ml-1) for 6 h before analysis. Culture superna-
tants were then collected and centrifuged at 1500 g for 15 min to
discard EC and debris. Endothelial MP were labelled using
annexin V-FITC and resuspended in binding buffer (Beckman-
Coulter Immunotech) as previously described (Combes et al.,
2004). MP present in supernatants were then quantified by flow
cytometry.
Quantification of MCP-1, RANTES and IL-6 release and
caspase-3 activation levels by ELISA
Confluent cells were washed with DMEM-F12 medium and stimu-
lated separately overnight with fresh culture medium containing
increasing concentrations of TNF (0, 0.01, 0.1, 1 and 10 ng ml-1).
For MCP-1, RANTES and IL-6, cell supernatants were harvested,
centrifuged to remove cell debris and stored at -80°C. After
thawing, samples were analysed for the presence of MCP-1,
RANTES and IL-6 using specific quantitative enzyme-linked
immunosorbent assays (ELISA) kits (R&D System Quantikine for
MCP-1 and RANTES; Becton Dickinson OptEIA for IL-6). For
active Caspase-3, cells were washed in PBS and cell extracts
were prepared according to the manufacturer’s instruction before
being analysed immediately by ELISA (R&D System Quantikine).
Each sample was tested in triplicate.
Statistics
Statistical analyses were performed with STATA 8 ©. Data were
analysed by the Kruskall–Wallis and Dunn’s pairwise tests.
Results are expressed as means  standard deviations. A value
of P < 0.05 was considered significant.
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